Curis (CRIS) Market Capitalization (2010 - 2026)
Curis' (CRIS) quarterly Market Capitalization came in at $1.0 million in Q2 2026, down 18.41% on a YoY basis from $1.2 million in Q2 2025, and up 91.27% quarter-over-quarter from $529881.6 in Q1 2026.
Analysis
Curis (CRIS) Market Capitalization (2010 - 2026) Analysis & Trends
Curis (CRIS) has reported Market Capitalization for 17 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Market Capitalization fell 18.41% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (down 18.41% YoY), and the FY2025 full-year result was $638103.9, down 33.87% from the prior year.
- Market Capitalization rose to $1.0 million in Q2 2026 per CRIS's latest filing, from $529881.6 in the prior quarter.
- Across five years, Market Capitalization topped out at $10.9 million in Q1 2022 and bottomed at $529881.6 in Q1 2026.
- Historically, Market Capitalization has averaged $2.6 million across 5 years, with a median of $2.0 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Market Capitalization plunged 90.59% in 2022, then surged 41.43% in 2023.
- Over 5 years, Market Capitalization stood at $2.7 million in 2022, then jumped by 41.43% to $3.8 million in 2023, then tumbled by 74.32% to $964860.8 in 2024, then plunged by 33.87% to $638103.9 in 2025, then jumped by 58.83% to $1.0 million in 2026.
- According to Business Quant data, Market Capitalization over the past three periods registered $1.0 million, $529881.6, and $638103.9 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Curis | 2.63 Mn | -2.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 529,881.61 |
| Dec 31, 2025 | 638,103.89 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 891,857.36 |
| Dec 31, 2024 | 964,860.82 |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 1.94 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Mar 31, 2023 | 2.88 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 4.52 Mn |
| Mar 31, 2022 | 10.91 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Sep 30, 2021 | 35.87 Mn |